Long‐term extension study of tofacitinib in refractory dermatomyositis is a research paper published in Arthritis & Rheumatology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P30‐AR‐070254
NIH
Grant: K23‐AR‐073927
National Institute of Neurological Disorders and Stroke
Grant: 5K23‐NS‐091379
NIAMS NIH HHS
Grant: K23 AR073927
NIH HHS
Grant: K23-AR-073927
NINDS NIH HHS
Grant: K23 NS091379
NIAMS NIH HHS
Grant: P30 AR070254
NIH HHS
Grant: P30-AR-070254
NINDS NIH HHS
Grant: 5K23-NS-091379
National Institutes of Health
Grant: 5K23AR073927-02
Skeletal Myopathy in Systemic Sclerosis: Devising a Classification Schema Predictive of Outcomes
National Institutes of Health
Grant: 5K23NS091379-04
Magnetic resonance imaging and spectroscopy biomarkers for facioscapulohumeral muscular dystrophy
National Institutes of Health
Grant: 1P30AR070254-01
Johns Hopkins Rheumatic Diseases Resource-based Core Center
Donald B. and Dorothy L. Stabler Foundation
Jerome L. Greene Foundation
Pfizer
FWCI
3.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals